Benjamin Huang

Benjamin Huang is a physician-scientist at the University of California San Francisco (UCSF) whose research program focuses on mouse cancer modeling, molecular therapeutics, functional genomics, and biomarker discovery in hematologic cancers. His work has significant implications for pediatric acute myeloid leukemia (AML) therapy and Ras-driven malignancies.

• Develops novel therapeutic strategies for pediatric AML through mouse models and clinical trial analysis
• Investigates Ras effector pathways and transcriptional programs in cancer
• Implements computational pipelines for integrated (epi)genetic data analysis
• Collaborates with North American Children's Oncology Group and participates in early-phase clinical trials
• Focuses on genetically stratified trials of innovative drug combinations

His research has produced over 15 publications in high-impact journals including J Clin Oncol, Cell, and Nature Cancer, with recent work demonstrating that high-risk AML patients benefit from hematopoietic stem cell transplantation in first remission. Huang's collaborations include primary sample analysis from clinical trials and exploration of novel therapeutic targets in Ras/NF1-driven cancers.

Scientific Awards

• St. Baldrick’s Foundation Fellowship Award (2016)
• Bleecher Junior Faculty Research Award (2017)
• Hyundai Hope on Wheels Scholar Award (2019)
• St. Baldrick's Foundation Scholar Award (2020)
• Rally Foundation Career Development Award (2020)
• UCSF School of Medicine Core Clerkship Teaching Award (2014)
• Alpha Omega Alpha Medical Honor Society (2010)
• UC Berkeley Outstanding Graduate Student Instructor Award (2006)